Searched for
SOMERSET CAPITAL PARTNERS
PE firm Somerset Indus closes $288 million Fund III, beats targetSomerset Indus Capital Partners closed its third fund at $288 million, exceeding targets, to invest in affordable healthcare across India. ...- NIIF raises $750 million for its second private market fundIndia's National Investment and Infrastructure Fund has raised a remarkable $750 million for its second private markets fund, set to empowe...
- PE-firm InvAscent buys out Somerset, invests Rs 265 Cr in Rajasthan-based hospital chain ApexLife sciences private equity firm InvAscent has acquired a significant stake in Apex Hospitals, investing $30 million (Rs 265 crore). This ...
- NIIF to make a $700-million first closure of $1 billion Private Markets Fund IINIIF is also launching its Master Fund II, targeting a commitment of about $3.5-4 billion. The New Development Bank (NDB) has committed $10...
- NIIF eyes $1 billion for second Private Markets FundNIIF is gearing up to secure approximately $1 billion for its second Private Markets Fund (PMF), according to people familiar with the matt...
- Wall Street snubs China for India in a historic markets shiftInvestors are paying close attention to the contrasting trajectories of two of Asia’s greatest powers. India, the world’s fastest-growing m...
- Some fund managers see merit in China's deeply discounted stocksU.S. asset manager Fidelity International is highlighting China's looser monetary policy and the government's recent 1 trillion yuan ($137....
- Emil raises Rs 150 cr from Somerset Indus Capital"The investment is through a mix of primary (Rs 120 crore) and secondary (Rs 30 crore) sale," said Tushar Korday director, Emil Pharmaceuti...
- Ujala Cygnus to raise Rs 150 crore from PE investorsUjala Cygnus is controlled by leading media house Amar Ujala through its healthcare arm Medicive Healthcare. Ghoshal owns 25% in Medicive. ...
- $83 bn in FY22: FDI will play a significant role in India’s future economic developmentSeveral sectors remained attractive to investors, including FMCG, IT, pharma, financial services, etc. Some of the top countries from where...
- GenWorks secures Rs 135 crore funding in the latest roundThe fragmented healthcare system has been under pressure, amplified by the Covid pandemic. Chronic care and elective surgeries took a beati...
- 'Best day ever': Billionaire Jeff Bezos has successful first space jauntThe 57-year-old American billionaire, wearing a blue flight suit and donning a cowboy hat, was joined by three crewmates for a trip to the ...
- Jeff Bezos, world's richest man, set for inaugural space voyageThe American billionaire is due to fly from a desert site in West Texas on an 11-minute voyage to the edge of space nine days after British...
- Stempeutics: The startup which uses donor stem cells to treat peripheral artery diseaseAnother company which works in a similar space in India include Kasiak Research, which is a part of Bharat Serums and Vaccines (BSVL).
- Investors feel the pulse of online pharma potentialVCs aim to close multiple deals despite a lack of clarity on regulatory issues in the segment
- Core Diagnostics scores Rs 84 crore in fresh funding in round led by Fidelity investment armsProceeds from the Series B round of funding, which also saw participation from existing investor Artiman Ventures, will be used by the Gurg...
- Cygnus Hospitals aims to have 50 units by March 2018Cygnus Hospitals, which operates a chain of super speciality units in Delhi and Haryana, aims to add another 40 hospitals in north India.
- Fidelity leads Rs 60 crore investment in Delhi-based healthcare chain Cygnus MedicareCygnus, whose promoters are four doctors, merged with Altius Healthcare in early 2013. The company reported revenues of Rs 68 crore in 2013...
- India Life Sciences Fund II raises Rs 865 crore in second fundThe oversubscription of India Life Sciences Fund II shows that investors are open to funds offering focused expertise in certain key indust...
- Somerset Indus Capital Partners buys minority stake in Prognosys & ChayagraphicsSomerset Capital's first fund, which raised $27 million (Rs 160 crore) is backed by US buyout firm Avista Capital and Health Evolution Part...
Load More
